Workbook Creative, Inc.

(805) 963-0439 | Toll-Free (800) 876-6425

www.workbookcreative.com LA / NY / UK

Vedolizumab® 

Prev Next
Previous

Histology of the Poster

illustration of Monoclonal antibody drug Vedolizumab®. An anti-integrin therapy with a selective mechanism of action, for use in primary types of inflammatory bowel disease — ulcerative colitis and Crohn's disease. 

Part of a series;  Drug's mechanism of action graphics at cellular level for pharmaceutical project.

Keywords: molecular biology, cellular biology, histology, pharmacology, virology, disease management
Next illustration of Drug's mechanism of action graphics at cellular level for pharmaceutical project, explaining how Chimerix’s novel oral antiviral, Brincidofovir, has enhanced intracellular uptake compared to Cidofovir. Brincidofovir has a monoacyl lipid side chain that enables it to rapidly enter by flip-flopping.

Keywords: molecular biology, cellular biology, histology, pharmacology, virology, disease management

Cidofovir versus Brincidofovir (oral antiviral)

Monoclonal antibody drug Vedolizumab®. An anti-integrin therapy with a selective mechanism of action, for use in primary types of inflammatory bowel disease — ulcerative colitis and Crohn's disease. Part of a series; Drug's mechanism of action graphics at cellular level for pharmaceutical project. Keywords: molecular biology, cellular biology, histology, pharmacology, virology, disease management

Keywords: Line with Color, Action, Corporate, Education, Health, Information Graphics, Medical, Product, Science, Scientific

© Mica Duran